Protalix BioTherapeutics, Inc. Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Protalix BioTherapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2010 to Q4 2023.
  • Protalix BioTherapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was $382M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $382M +$771M Dec 31, 2023 10-Q 2024-11-14
Q4 2022 -$390M -$14.9M -3.98% Dec 31, 2022 10-K 2024-03-14
Q4 2021 -$375M -$27.6M -7.94% Dec 31, 2021 10-K 2023-02-27
Q4 2020 -$347M -$6.52M -1.91% Dec 31, 2020 10-K 2022-03-31
Q4 2019 -$341M -$18.3M -5.67% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $341M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $338M Jun 30, 2019 10-Q 2019-08-08
Q4 2018 -$323M -$26.5M -8.94% Dec 31, 2018 10-K 2020-03-12
Q4 2017 -$296M -$83.4M -39.2% Dec 31, 2017 10-K 2019-03-18
Q4 2016 -$213M -$29.4M -16% Dec 31, 2016 10-K 2018-03-06
Q4 2015 -$183M +$58M +24% Dec 31, 2015 10-K 2017-03-16
Q4 2014 -$241M -$29.9M -14.2% Dec 31, 2014 10-K 2016-03-08
Q4 2013 -$211M -$27.8M -15.1% Dec 31, 2013 10-K 2015-03-12
Q4 2012 -$184M -$11.6M -6.76% Dec 31, 2012 10-K 2014-03-13
Q4 2011 -$172M -$36.5M -27% Dec 31, 2011 10-K 2013-02-28
Q4 2010 -$135M Dec 31, 2010 10-K 2012-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.